Comparison of Bi-level Erector Spine Plane Block and Combined Pectoral I-II Block in Breast Surgery
Comparison of Postoperative Efficacy of Ultrasound-guided Bi-level Erector Spine Plane Block and Combined Pectoral I-II Block in Breast Cancer Surgery
1 other identifier
interventional
70
1 country
1
Brief Summary
In this study, we compared ultrasound-guided modified pectoral nerve (PECS) block and bi level erector spinae plane (ESP) block on postoperative analgesic effect in breast surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Jan 2020
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
December 27, 2020
CompletedFirst Posted
Study publicly available on registry
December 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2021
CompletedJune 29, 2021
June 1, 2021
1 year
December 27, 2020
June 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Morphin consumption
Patients in both groups will provide with intravenous patient-controlled analgesia device containing morphine for postoperative analgesia.
during postoperative 24 hour
numerical rating scale (NRS)
A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable
during postoperative 24 hour
Study Arms (2)
Bi-level erector spinae plane block
EXPERIMENTALBi-level ultrasound (US)-guided Erector spinae plane block (ESP) with 30 ml 0.25% bupivacaine at the T2 andT4 vertebral level will performe preoperatively to all patients in the ESP group.
Modified pectoral nerve block
EXPERIMENTALUltrasound (US)-guided modified pectoral nerve block (PECs) with 30 ml 0.25% bupivacaine will performe preoperatively to all patients in the PECs group.
Interventions
Bi-level ultrasound (US)-guided Erector spinae plane block (ESP) with 30 ml 0.25% bupivacaine at the T2 andT4 vertebral level will performe preoperatively to all patients in the ESP group.
Ultrasound (US)-guided modified pectoral nerve block (PECs) with 30 ml 0.25% bupivacaine will performe preoperatively to all patients in the PECs group.
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists Classification (ASA) I-II patients
- aged patients
- patients who scheuled elective breast cancer surgery
You may not qualify if:
- American Society of Anesthesiologists Classification (ASA) III-IV patients
- patients with coagulopathy
- patients with infection at the injection site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kocaeli University
Kocaeli, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sevim Cesur, MD
Kocaeli University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DR
Study Record Dates
First Submitted
December 27, 2020
First Posted
December 30, 2020
Study Start
January 1, 2020
Primary Completion
January 10, 2021
Study Completion
January 15, 2021
Last Updated
June 29, 2021
Record last verified: 2021-06